- Web report
- Published:
Symposium on Recent Novel Therapies in the Treatment of Acute Coronary Syndromes
Critical Care volume 3, Article number: webreport10 (1999)
Overview
A new symposium has recently been added at the site, entitled 'Recent Novel Therapies in the Treatment of Acute Coronary Syndromes'. Presented as a satellite symposium on Saturday 6 March 1999 at the 1999 American College of Cardiology meeting, this symposium presented new information on the use of ion pumpinhibitors and thrombolytics in the management of cardiovascular disease.
The faculty and topics included:
Robert Roberts, MD, Program Chairman
Metin Avkiran, PhD: Scientific basis of NHE in acute cardiac ischemia
John Speer Schroeder, MD: Clinical potential of NHE inhibition - the GUARDIAN trial
Pierre Theroux, MD, Program Co-Chairman: Panel discussion/Question and answers
Hirudin is superior to heparin in acute coronary syndromes
Point: James H Chesebro, MD
Counterpoint: Robert M Califf, MD
Transcription-only and Multimedia (RealPlayer® technology required) versionsare available both providing the full slide show and the text of the presentations.
Other comments
March 1999.
Evaluation
None.
References
Medical Matrix Symposia on the Web. [http://www.medmatrix.org/symposia]
Rights and permissions
About this article
Cite this article
Nattino, G. Symposium on Recent Novel Therapies in the Treatment of Acute Coronary Syndromes . Crit Care 3, webreport10 (1999). https://doi.org/10.1186/ccf-1999-webreport10
Published:
DOI: https://doi.org/10.1186/ccf-1999-webreport10